How should stress-related mucosal injury be prophylaxed in critically ill patients with major risk factors such as prolonged mechanical ventilation, coagulopathy, severe sepsis, major trauma, burns, intracranial injury, or high-dose steroids?

Stress Ulcer Prophylaxis in Critically Ill Patients

Critically ill patients with major risk factors including prolonged mechanical ventilation (>48 hours), coagulopathy, severe sepsis/septic shock, major trauma, burns, intracranial injury, or high-dose steroids should receive stress ulcer prophylaxis with either a proton pump inhibitor (PPI) or histamine-2 receptor antagonist (H2RA). 1, 2

Risk Stratification: Who Needs Prophylaxis

The most robust evidence identifies two independent major risk factors that dramatically increase bleeding risk 3:

• Mechanical ventilation >48 hours (odds ratio 15.6)
• Coagulopathy (odds ratio 4.3)

Additional high-risk conditions warranting prophylaxis include 4:

• Shock requiring vasopressors
• Chronic liver disease
• Severe sepsis or septic shock
• Major burns
• Traumatic brain injury
• High-dose corticosteroid therapy

Patients with these risk factors have a 3.7% incidence of clinically important bleeding, compared to only 0.1% in those without risk factors 3. This means you need to treat 27 high-risk patients to prevent one bleeding event, versus 1,000 low-risk patients 5.

Medication Selection

Either PPIs or H2RAs are acceptable first-line agents 2, 4. The 2024 Society of Critical Care Medicine guidelines provide a conditional recommendation for either class, as both reduce clinically important gastrointestinal bleeding with moderate certainty of evidence 2.

Key considerations:

• The 2016 Surviving Sepsis Campaign guidelines showed a weak preference for PPIs over H2RAs (grade 2D) 1
• However, the most recent 2024 guidelines consider them equivalent 2
• No mortality benefit has been demonstrated with either agent 6

Dosing: Use standard prophylactic doses, not high-dose therapy 2. High-dose regimens provide no additional benefit and increase adverse effects.

Route of Administration

Either enteral or intravenous routes are acceptable 2. Choose based on:

• Availability of enteral access
• Gastrointestinal function
• Hemodynamic stability

Role of Enteral Nutrition

Enteral nutrition itself provides protective effects against stress-related mucosal injury 4, 7. The 2024 guidelines suggest administering enteral nutrition to reduce clinically important bleeding (conditional recommendation, moderate certainty) 4.

However, enteral nutrition alone is insufficient in hypersecretory states (burns, head trauma) or when major risk factors are present 7. In these situations, pharmacologic prophylaxis must be added even if the patient tolerates enteral feeds.

When to Discontinue Prophylaxis

Discontinue stress ulcer prophylaxis when risk factors resolve 2. Specifically:

• Stop before ICU transfer to prevent inappropriate continuation 2
• Reassess daily for persistent risk factors
• In patients on prophylaxis before ICU admission without current risk factors, review indications and consider discontinuation 2

This is critical because only 1.5% of all critically ill patients develop clinically important bleeding 3, and unnecessary prophylaxis exposes patients to potential harms without benefit.

Important Caveats

Ventilator-associated pneumonia concerns: Older literature suggested H2RAs and PPIs might increase pneumonia risk by raising gastric pH 5. However, the 2024 guidelines note this risk may be increased when combining prophylaxis with enteral nutrition 4. Despite this theoretical concern, the reduction in bleeding risk generally outweighs pneumonia concerns in truly high-risk patients.

Mortality impact: No study has demonstrated that stress ulcer prophylaxis reduces mortality 6. However, when bleeding occurs, mortality is substantially higher (48.5% vs 9.1% in non-bleeding patients) 3, suggesting prevention of bleeding in high-risk patients remains clinically important.

Avoid prophylaxis in low-risk patients: Patients without mechanical ventilation >48 hours or coagulopathy have minimal bleeding risk and should not receive prophylaxis 1, 3. Overuse of acid suppression exposes patients to unnecessary medication risks and costs.

Practical Algorithm

1. Identify risk factors: Mechanical ventilation >48h, coagulopathy, shock, liver disease, sepsis, burns, head injury, high-dose steroids
2. If ≥1 major risk factor present: Start PPI or H2RA (either enteral or IV)
3. Initiate/continue enteral nutrition when feasible as adjunctive therapy
4. Daily reassessment: Discontinue when risk factors resolve
5. Before ICU discharge: Stop prophylaxis unless ongoing indication exists

1, 2, 4, 3